Pure Global

Biventricular Versus Right Ventricular Pacing - Trial NCT06298669

Access comprehensive clinical trial information for NCT06298669 through Pure Global AI's free database. This phase not specified trial is sponsored by Indiana University and is currently Suspended. The study focuses on Heart Failure. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06298669
Suspended
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06298669
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Biventricular Versus Right Ventricular Pacing
Selection of Cardiac Resynchronization Therapy Pacing Modalities in Patients Supported by LVADs

Study Focus

Heart Failure

Biventricular Pacing

Interventional

device

Sponsor & Location

Indiana University

Indianapolis, United States of America

Timeline & Enrollment

N/A

Aug 09, 2023

Feb 01, 2025

28 participants

Primary Outcome

6 Minute Walk Test Performance

Summary

The study is a randomized, single-blind crossover prospective study in which investigators
 will determine the clinical outcomes of cardiac resynchronization therapy (CRT) pacing
 modalities in patients with left ventricular assist devices (LVAD). Only patients are
 blinded. This is a small-scale study from which future larger scale randomized controls can
 be performed. The primary endpoint will be the effect of BiV and RV pacing setting on the
 6-minute walk test.

ICD-10 Classifications

Heart failure
Heart failure, unspecified
Congestive heart failure
Hypertensive heart disease with (congestive) heart failure
Left ventricular failure

Data Source

ClinicalTrials.gov

NCT06298669

Device Trial